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Abstract
Background Cachexia involves unintentional body weight
loss including diminished muscle and adipose tissue mass
and is associated with an underlying disease. Systemic
overexpression of IL-6 accelerates cachexia in the Apc
Min/+
mouse, but does not induce wasting in control C57BL/6
mice. With many chronic diseases, chronic inflammation
and metabolic dysfunction can be improved with moderate
exercise. A direct effect of regular moderate exercise on the
prevention of IL-6-induced cachexia in the Apc
Min/+ mouse
has not been investigated. The purpose of this study was to
assess the effects of exercise on the development of
cachexia in the Apc
Min/+ mouse.
Methods Mice were randomly assigned to moderate tread-
mill exercise (18 m/min, 1 h, 6 days/week, 5% grade) or
cage control (CC) groups from 6 to 14 weeks of age. At 12
weeks of age, mice were electroporated with either IL-6-
containing or control plasmid into the quadriceps muscle.
Mice were killed after 2 weeks of systemic IL-6 over-
expression or control treatment.
Results IL-6 overexpression induced an 8% loss in body
weight in CC mice, which was significantly attenuated by
exercise. IL-6 overexpression in CC mice increased fasting
insulin and triglyceride levels, which were normalized by
exercise, and associated with increased oxidative capacity, an
induction of AKT signaling, and a repression of AMPK
signalinginmuscle.Theseexercise-inducedchangesoccurred
despite elevated inflammatory signaling in skeletal muscle.
Conclusion We conclude that moderate-intensity exercise
can attenuate IL-6-dependent cachexia in Apc
Min/+ mice,
independent of changes in IL-6 concentration and muscle
inflammatory signaling. The exercise effect was associated
with improved insulin sensitivity and improved energy
status in the muscle.
Keywords Inflammation.Colorectal cancer.Insulin
resistance.Oxidative capacity
1 Introduction
Cachexia, characterized by severe loss of body weight,
including both muscle and adipose mass, develops in
numerous diseases, including cancer, HIV-AIDS, and chronic
renal failure [1]. This condition is also associated with
chronic inflammation, hypermetabolism, fatigue, impaired
immune function, and overall weakness, leading ultimately
to increased morbidity and mortality. Nearly 50% of all
cancer patients are diagnosed with cachexia, and cachexia
plays a significant role in 20% of all cancer-related deaths
[2]. Although modeling cachexia in rodents has been proven
extremely beneficial for understanding the regulation of this
wasting process, the underlying disease may ultimately
impact the specific mechanisms responsible for the initiation
and progression of the wasting process [3]. The Apc
Min/+
mouse is an established model of colon cancer that develops
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other cancer cachexia models and provides physiologic
relevance to the human condition. At codon 850 in the
Adenomatous polyposis coli (Apc), gene there is a nonsense
mutation that predisposes the mice to intestinal adenomas
[4]. Cachexia is initiated around 14 weeks of age, and the
averagelifespanofthesemiceisapproximately20–26weeks.
The initiation and progression of cachexia in this mouse is
directly related to the intestinal tumor burden and circulating
IL-6 levels [5].
Regular moderate-intensity exercise reduces the risk for
colon cancer and increases survival after diagnosis with colon
cancer [6]. A well-established mechanism that exercise has,
which may play a role in cancer prevention, is associated
with lowering the level of inflammation [7–9]. Several
studies have shown that exercise also decreases the incidence
of tumor growth in the Apc
Min/+ mouse and other rodent
cancer [10–16]. Although exercise has been widely men-
tioned as having a great potential for preventing and slowing
the development of cancer cachexia, few studies address the
mechanisms related to this potential benefit. A major
limitation to mechanistic studies is that the therapy should
attenuate cachexia, independent of effects on the underlying
disease [17]. Treating the underlying disease is mechanisti-
cally and physiologically different from treating the cachexia
associated with the disease. We recently demonstrated that
Apc
Min/+ mice decrease voluntary wheel running distance
with the progression of cachexia [12] and that this change is
associated with a decrease in muscle oxidative capacity in
both primarily fast- and slow-type skeletal muscle [18].
Chronic fatigue, which also leads to a decrease in activity
and potentially a decrease in oxidative capacity, is common
among cancer patients [19, 20]. The decrease in muscle
oxidative capacity is one potential mechanism for stimulating
the progression of cachexia [18] that may also play a part in
altered metabolism during cachexia. It remains to be
determined whether maintenance of muscle oxidative capac-
ity through increased muscle contraction, i.e., exercise, can
slow or prevent the progression of cachexia in the absence of
effects on the underlying disease.
Insulin resistance develops in many cancer patients [21,
22], and the association between insulin resistance and
cancer cachexia is widely acknowledged [17]; however, a
direct role for insulin resistance in the development and
progression of cancer cachexia is uncertain [22]. Pharmaco-
logical agents that improve insulin resistance have been
effective, decreasing polyp formation and attenuating wast-
i n gi nt u m o r - b e a r i n gm i c e[ 22, 23]. Exercise is also
commonly used to increase insulin sensitivity in various
disease states, including diabetes and obesity [24, 25]. In
healthy rodents, exercise improves both glucose tolerance
[26] and insulin sensitivity [27]. Further examination for the
potential for exercise to inhibit progression of cachexia
through improved insulin action [28] and/or a reduction in
chronic systemic inflammation [29–32]i sw e l lj u s t i f i e d .
Plasma concentrations of interleukin-6 (IL-6), an inflam-
matory cytokine, are correlated with the progression of
cachexia in late-stage cancer patients [33]. Although not all
patients or animal models demonstrate this IL-6 dependency,
the Apc
Min/+ mouse and the C26 ectopic tumor cell models of
colon cancer are well-characterized models in which elevated
IL-6 levels have an established role in the progression of
cachexia [5, 34] .T h er e g u l a t o r yf u n c t i o no fI L - 6i sn o tw e l l
defined. It has both pro-inflammatory and anti-inflammatory
properties as well as the ability to activate transcription of
genes involved in cell proliferation, differentiation, and
apoptosis [35]. Contracting skeletal muscle synthesizes and
releases IL-6, and circulating IL-6 increases transiently with
exercise [9]. The function of transiently increased, exercise-
induced IL-6 has been linked to metabolic signaling with
exercise [9], distinct from chronically elevated IL-6 levels
associated with inflammation [3]. Chronically elevated IL-6
levels have been associated with insulin resistance and can
be used to predict the development of type 2 diabetes in
humans [36]. It has also been shown to increase fasting
glucose levels in a dose-dependent manner in healthy human
subjects [37]. IL-6 has been shown to suppress insulin action
through the activation of STAT3, which then acts on the
insulin receptor suppressing the activation of IRS-1 and
downstream targets [38, 39].
Increased circulating IL-6 levels are associated with the
progression of cachexia in Apc
Min/+ mice [5]. We have also
demonstrated that IL-6 overexpression in Apc
Min/+ mice
accelerates the progression of cachexia and increases the
intestinal/colon tumor burden [5]. Although there is an
inverse relationship between voluntary wheel running dis-
tance and the development of cachexia in Apc
Min/+ mice [12]
and regular treadmill exercise can reduce tumor growth in
these mice [40], the effect of regular moderate exercise on
the prevention and progression of IL-6-induced cachexia in
the Apc
Min/+ mouse has not been investigated. The purpose
of the current study was to determine the effect of regular
moderate treadmill exercise on the development and pro-
gression of IL-6-induced cachexia in the Apc
Min/+ mouse. We
hypothesized that exercise training during systemic IL-6
overexpression would prevent muscle mass loss and fat
mass loss and also attenuate changes in systemic glucose
metabolism. Additionally, we hypothesized that regular
moderate exercise training would benefit skeletal muscle by
increasing oxidative capacity, improving metabolic signaling,
and reducing muscle inflammatory signaling despite high
circulating IL-6 levels and intestinal tumors. To test these
hypotheses, treadmill-trained or cage control non-cachectic
Apc
Min/+ mice were subjected to 2 weeks of systemic IL-6
overexpression between 12 and 14 weeks of age. Age-
matched wild-type mice served as additional controls.
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glucose tolerance were monitored over the 2-week study.
Muscle and fat mass were examined at the end of the study
and the quadriceps muscle examined for changes in protein
expression related to oxidative capacity, inflammatory
signaling, and metabolic signaling. We have previously
demonstrated that skeletal muscle IL-6 mRNA expression
is not induced during the progression of cachexia [18], but
elevated systemic IL-6 is the source of increased STAT3
signaling in muscle. Although not a primary outcome of the
study, muscle protein expression data are also presented for
the quadriceps muscle directly overexpressing IL-6 due to
electroporation as an opportunity to compare systemic effects
with the combination of systemic and local IL-6 over-
expression. Muscle expression data are also presented for
wild-type mice overexpressing IL-6 but not having a tumor
burden.
2 Methods
2.1 Animals
Apc
Min/+ male mice, purchased from Jackson Laboratories,
were crossed with C57BL/6 female mice at the Animal
Resource Facilities at the University of South Carolina.
Using a tail snip taken at the time of weaning, mice were
genotyped for heterozygous expression of the Apc gene
using RT-PCR. Male mice were housed four to five per
cage, with Apc
Min/+ mice kept in separate cages from
control C57BL/6 mice. All mice were kept on a 12:12-
h light/dark cycle starting at 7:00AM. Mice had unrestricted
access to rodent chow (HarlanTeklad Rodent Diet, no.
8604) and water. Mice were weighed weekly. A subset of
Apc
Min/+ mice (n=10) was used for an additional experi-
ment to examine IL-6 and triglyceride levels with varying
degrees of cachexia. While body weights, muscle weights,
and fat pad mass from this subset of mice have been
previously published [18], the IL-6 and triglyceride
measurements from these mice have not been previously
published. Blood was collected at 10, 14, and 20 weeks and
analyzed for triglycerides and IL-6; mice were killed at
20 week and stratified by degree of cachexia into mild or
severe groups based on extent of weight loss [18]. The
University of South Carolina’s Institutional Animal Care and
Use Committee approved all animal experimentation.
2.2 Treadmill protocol
At 5 weeks of age, mice were grouped into either exercise or
cage control (Fig. 1); after 3 days of acclimation, they started
their training as previously described [40]. Briefly, acclima-
tion consisted of running at a 5% grade for a total of 20 min
with a gradual increase in speed starting at 10 m/min and
increasing to 18 m/min. After the acclimation period, mice
started on a training regimen that consisted of a 5-min warm-
up at 10 m/min at 5% grade, followed by 55 min of running
at 18 m/min at 5% grade. All training was conducted at the
beginning of the dark cycle (1900 hours) in the dark. Mice
were encouraged to run by gentle prods, as needed. Mice ran
6 days a week. After electroporation at 12 weeks, the mice
received a 2-day break from exercise and then mice ran until
1 4w e e k so fa g e ,w h e nt h e yw e r ek i l l e d .
2.3 Grip strength and RotoRod performance
In a subset of mice (n=5–6 per treatment group), combined
hindlimb and forelimb rodent grip strength was measured
with the Grip Tester (Columbus Instruments, Columbus,
OH). Mice were placed with all four limbs on a metal grid
mounted at a 45° angle connected to a force transducer.
Mice were pulled by the tail until they let go of the grid.
Each mouse went through a series of two sets of five
repetitions of force measurements, with a 2- to 3-min rest
period between each set. The highest and the lowest scores
from each set of five repetitions were removed and the
remaindersaveragedtoprovideameanforcemeasurementfor
each mouse.
Neuromuscular performance was assessed (n=5–6p e r
treatment group) with the RotoRod (Columbus Instruments).
The protocol consisted of a ramping protocol from 0 to
25 rpm over a period of 90 s. The protocol continued at
25 rpm from 90 to 120 s. Each mouse performed the
protocol three times, with each trial separated by a 1- to 2-
min rest period. The longest time of the three tests was
recorded for each mouse. Mice were tested for grip strength
and RotoRod performance at 11 and 14 weeks of age. The
mice were acclimated to the testing procedures for 3 days
prior to the start of testing.
2.4 Cage activity monitoring
At 4 and 12 weeks of age, a subset of mice (n=5–6) were
single-housed and placed in activity monitor cages (Opto-M3
Activity Meter, Columbus Instruments). Activity was mea-
sured for 10 h during the dark cycle (9PM–7AM); the number
of beams crossed in an X–Y plane was recorded for two
consecutive nights. Food consumption was also recorded
during this time while the mice were single-housed.
2.5 IL-6 overexpression
At 12 weeks of age, mice were electroporated with either an
empty vector or an IL-6 plasmid as previously described
[5]. The IL-6 plasmid, driven by the CMV promoter, was
used to increase endogenous IL-6 production in the mice.
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and oxygen during the procedure. While unconscious, the
right leg was shaved and cleaned with alcohol. A small
incision was made over the right quadriceps muscle and
50 μg of either control vector or IL-6 plasmid injected into
the muscle. To promote uptake of the plasmid into the
myofibers, a series of eight 100-V pulses lasting 50 ms
each were used on the quadriceps muscle. The skin was
then closed with a wound clip. Mice were killed 2 weeks
later.
2.6 Tissue collection
At the time of killing (14 weeks), mice were given a
subcutaneous injection of ketamine–xylazine–acepromazine
cocktail (1.4 mL/kg body weight) and tissues were collected
as previously described [40]. Briefly, tissues were dissected
out, weighed, and then snap-frozen in liquid nitrogen and
stored at −80°C.
2.7 Intestinal tissue collection
Intestinal tissue collection was performed as described
previously, with a slight modification [41]. Briefly, the
small intestines were dissected at the distal end of the
stomach and at the proximal end of the cecum. The large
intestine was removed from the distal end of the cecum to
the anus. Mesentery adipose tissue was removed with
tweezers and the small intestine cut into four equal sections.
All intestinal sections were flushed with phosphate-buffered
saline (PBS), opened longitudinally with a pair of scissors,
and flattened with a cotton swab between two pieces of
blotting paper. Intestinal sections were fixed in 4% parafor-
maldehyde(PFA)inPBSovernight and transferred toPBSfor
storage at 4°C for further analysis.
2.8 Polyp counts
Polyp counts were performed as previously described [40,
41]. Intestinal sections from all animals were fixed with 4%
PFA, stained and briefly in 0.1% methylene blue, then
placed under a dissecting microscope. The polyp number
was counted by the same investigator in a blind manner
using tweezers to pick through the intestinal villi and
identify polyps. Polyp sizes were categorized as large
(>1 mm in diameter) or small (≤1m m ) .
2.9 Glucose tolerance test
To determine whether IL-6 overexpression or exercise had
an effect on glucose clearance, a glucose tolerance test was
conducted at 12 and 14 weeks of age in a subset of animals
(n=6–7) after an overnight fast. A 20% glucose solution
(0.1 mL/g body weight) was administered via intraperito-
neal injection. Blood glucose was measured with a
handheld glucometer (Bayer CONTOUR®) prior to the
glucose injection and at15, 30, 60, 90, and 120 min following
the glucose injection. Blood was collected from the tail vein
for insulin and glucose analysis at each time point. HOMA
index was calculated fasting insulin (μU/m)×fasting glucose
(mmol/l)/22.5 [42].
2.10 Enzyme-linked immunosorbent assays
Blood was collected at 12 and 14 weeks of age via a retro-
orbital sinus puncture and centrifuged at 10,000×g for 10 min.
Plasma was collected and stored at −80°C until analysis.
Using commercial ELISA kits for insulin (Millipore, Billerica,
MA), IL-6 (Invitrogen, Fredrick, MD), and adiponectin and
leptin (R&D Systems, Minneapolis, MN) according to the
manufacturer’s instructions, circulating levels of fasting
insulin, IL-6, adiponectin, and leptin were measured.
2.11 Plasma triglycerides and glycerol
After an overnight fast, blood was collected from the tail vein
in capillary tubes. Plasma triglycerides were determined in
3 μL aliquots enzymatically using a colorimetric assay from
ThermoDMA (Thermo ElectronCorp.,Melbourne,Australia).
Glycerol was measured enzymatically using a glycerol assay
kit (Cayman, Ann Arbor, MI).
2.12 Western blotting
Briefly, frozen quadriceps were homogenized in Mueller
buffer and the protein concentration determined by the
Bradford method. Crude homogenates (30–60 g) were
fractionated on 8–15% polyacrylamide gels. Gels were
transferred to PVDF membranes overnight, and Ponceau
staining was used to visually confirm the gel transfer and
equal loading. Membranes were blocked in 5% Tris-buffered
saline with 0.1% Tween 20 (TBST) milk for 1 h at room
temperature. Primary antibodies for phosphorylated-STAT3
(Y705), phosphorylated NFkB p65 (S468), p-AKT (T308),
p-AMPK (T172), cytochrome C, COX IV, total AKT, total
AMPK, total STAT3, and total NFkB (p65; Cell Signaling)
were incubated at dilutions of 1:100 to 1:2,000 overnight at
4°C in 1% TBST milk. Secondary anti-rabbit or anti-mouse
IgG-conjugated secondary antibodies were incubated with the
membranes at 1:2,000 to 1:5,000 dilutionsfor 1 h in 1% TBST
milk.Enhancedchemiluminescence(GEHealthcare)wasused
to visualize the antibody–antigen interactions and developed
by autoradiography (Kodak, Biomax, MR). Digitally scanned
blots were analyzed by measuring the integrated optical
density of each band using digital imaging software (Scion
Image, Frederick, MD).
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Results are reported as the means ± SE. Variables were
analyzed with two-way ANOVA (IL-6 overexpression ×
exercise) to assess significant effects and interactions within
each genotype. Post hoc analyses were performed with
Student–Newman–Keuls methods. A pre-planned t test was
run (Min × Min + IL-6) in the cage control animals. The
accepted level of statistical significance was p<0.05.
3 Results
3.1 Body weight, growth, food consumption,
and tumor burden
It has previously been shown that overexpressing IL-6 can
accelerate cachexia in Apc
Min/+ mice, but does not induce
cachexia in wild-type C57BL/6 mice [5]. The current study
extends our previous work by overexpressing IL-6 at a young
age, just prior to the onset of cachexia, then evaluating the
effects of exercise despite increasing plasma IL-6 concen-
trations. IL-6 was overexpressed for 2 weeks, starting at
12 weeks of age. Exercise with or without IL-6 over-
expression had no effect on the overall rate of growth, as
measured by the change in tibia length. Systemic IL-6
overexpression is known to cause growth retardation in
rodents [43]. Two weeks of IL-6 overexpression tended to
suppress the growth rate in wild-type mice (p=0.06, Fig. 2a),
but did not cause them to lose weight. Exercise alone had no
effect on body weight in either wild-type or Apc
Min/+ mice.
IL-6 overexpression significantly reduced the body weight of
Apc
Min/+ mice at 14 weeks of age (7.8%; Fig. 1b and Table 1),
while exercise effectively prevented the IL-6-induced decrease
in body weight in Apc
Min/+ mice (Fig. 2b). IL-6 levels in non-
exercising cage control Apc
Min/+ mice were significantly
correlated with body weight loss from 12 to 14 weeks of
age (Fig. 2c). Two weeks of IL-6 overexpression in Apc
Min/+
mice induced a significant body weight loss that was
suppressed by exercise. Food consumption was monitored
both before and after the 2 weeks of IL-6 overexpression in
sedentary and exercised mice (Table 1). At 12 weeks of age,
food consumption was not statistically different between
sedentary wild-type (0.12±0.01 g/g body weight per day)
and sedentary Apc
Min/+ mice (0.13±0.01 g/g body weight per
day). Two weeks of IL-6 overexpression significantly altered
food intake. In wild-type mice, there was a main effect of IL-6
regardless of exercise to decrease food consumption. Non-
exercising Apc
Min/+ mice overexpressing IL-6 also tended to
decrease food consumption (p=0.06). Exercise alone in the
Apc
Min/+ mice significantly decreased food consumption, and
exercise with IL-6 overexpression restored food consumption
to control levels (Table 1). Food consumption did not
correlate with changes in body weight in the cage control
Apc
Min/+ (r
2=0.14, p=0.86) or wild-type mice (r
2=0.38, p=
0.53) overexpressing IL-6. Plasma IL-6 levels from electro-
porated animals ranged from 21 to 165 pg/mL in Apc
Min/+
mice and from 0 to 8 pg/mL in vector-treated Apc
Min/+ mice.
Exercise had no effect on circulating IL-6 levels or the
overall rate of growth in Apc
Min/+ mice. However, exercise
Fig. 1 Schematic of experimental design. Mice started the exercise
regimen at 6 weeks of age, after being acclimated to the treadmill at
5 weeks of age. Mice ran 6 days/week for 1 h at 18 m/min at the
beginningofthedarkcycle.At12weeksofage,functionalmeasurements
were taken includinggrip strength and RotoRod performance. A glucose
tolerance test was conducted and then the mice were electroporated.
After 2 weeks of IL-6 overexpression (14 weeks), functional measures
and a glucose tolerance test were conducted and mice were killed
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food consumption in Apc
Min/+ mice overexpressing IL-6.
Two weeks of IL-6 overexpression did not significantly alter
total tumor number (data not shown); however, exercise
significantly decreased the proportion of large tumors in
Apc
Min/+ mice by ∼20% (Table 1). This is consistent with
previous data demonstrating that moderate treadmill exercise
decreased the intestinal tumor burden in Apc
Min/+ mice
[13, 40]. Decreased tumor burden is thought to be a result
of a decrease in inflammation, but with the current model,
IL-6 remained high even with exercise (Table 1).
3.2 Muscle, fat, spleen, and testes mass
Quadriceps muscle mass was recorded at the time of killing.
The study performed electroporation on the right quadriceps
muscle. The experimental design allowed the examination of
the right quadriceps muscle overexpressing IL-6 and the left
quadriceps muscle only exposed to high systemic IL-6.
Systemic IL-6 overexpression caused a 13% decrease in mass
of thenon-electroporatedleft quadricepsmusclefrom Apc
Min/+
mice, and this loss was blocked by exercise. In contrast,
systemic IL-6 overexpression in wild-type mice did not affect
quadriceps muscle mass (Fig. 2d). However, local muscle
IL-6 overexpression caused muscle mass loss in both the
wild-type (−13%) and the Apc
Min/+ mice (−30%) in the
electroporated right quadriceps, which could not be rescued
by exercise (Fig. 2e).
Wild-typemouse epididymalfat pad masswas not affected
byIL-6overexpression,buttherewasasignificantmaineffect
of exercise to reduce epididymal fat mass 25% regardless of
IL-6concentration.Apc
Min/+ mouse fat pad mass was reduced
30% by IL-6. Despite the positive effects of exercise on body
weight and muscle mass loss in Apc
Min/+ mice, epididymal
fat pad mass loss was not attenuated by exercise (Fig. 2f). As
expected, spleen weight was twofold greater in control
Apc
Min/+ mice compared with control wild-type mice. IL-6
overexpression further increased Apc
Min/+ spleen weight by
25%; exercise had no effect on this IL-6 effect, which is
consistent with the lack of effect of exercise on inflammation.
There was no effect of IL-6 overexpression or exercise on
wild-type spleen weight (Table 1).
IL-6 overexpression in sedentary Apc
Min/+ mice that lost
body weight also had a reduction in quadriceps muscle and
epididymal fat pad mass (Fig. 2f) and an increased spleen
weight (Table 1). When comparing the sedentary IL-6-
overexpressing Apc
Min/+ mice that lost body weight to the
exercising IL-6-overexpressing Apc
Min/+ mice that were
weight-stable, the exercising mice maintained quadriceps
mass in the systemically exposed muscle. Exercise had no
effect on the IL-6-induced loss of epididymal fat or increase
in spleen size and was unable to rescue muscle mass in the
right quadriceps overexpressing IL-6.
3.3 Physical activity and functional performance
It has previously been shown that voluntary wheel running,
as a measure of cage activity, decreases with severity of
cachexia [10–16]. In the present study, ambulatory cage
activity was measured as the number of times the mouse
Table 1 Effect of exercise and IL-6 overexpression on body weight and growth in wild-type and Apc
Min/+ mice
C57BL/6 Apc
Min/+
CC vector CC IL-6 Ex vector Ex IL-6 CC vector CC IL-6 Ex vector Ex IL-6
N 12 11 13 12 12 15 14 12
BW 12 weeks 24.9±0.4 24.3±0.4 24.2±0.4 24.7±0.6 23.2±0.4 23.5±0.3 22.7±0.4 22.7±0.4
BW 14 weeks 25.9±0.3 24.6±0.4 25.2±0.4 25.5±0.7 23.2±0.3 21.8±0.4
a 22.8±0.4 22.5±0.5
a
Tibia length 17.2±0.1 17.2±0.1 17.1±0.1 17.3±0.1 17.0±0.1 16.9±0.1 17.1±0.1 17.1±0.1
Plasma IL-6 (pg/mL) 0.0±0.0 103.2±12.1
a 0.0±0.0 118.7±12.1
a 5.5±2.4 102.5±23.8
a 5.8±2.2 87.9±6.0
a
% Polyps >1 mm 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 59.3±5.9 54.5±3.6 30.8±3.6
c 40.8±2.9
c
Spleen (mg) 147±18 120±18 146±31 151±27 284±30 358±22
a 287±32 359±48
a
14-week food
consumption
0.16±0.01 0.10±0.01
a 0.14±0.01 0.11±0.01
a 0.16±0.01 0.11±0.01
b 0.11±0.01
b 0.16±0.03
Body weights were measured at 12 weeks (pre) and again at 14 weeks (post) after 2 weeks of IL-6 overexpression (cage control). Tibia length was
measured at 14 weeks as an index of body size. Plasma IL-6 levels were measured after 2 weeks of overexpression. Incidence of large polyps (≥1m m )
was measured in the distal half of the small intestine at 14 weeks of age as an index of tumor burden. Values are means±SE. Data were analyzed with
two-way ANOVAwithin each genotype. Significance was set at p≤0.05
BW body weights, CC cage control
aEffect of IL-6
bDifferent from the CC vector
cEffect of exercise
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10-h period of the dark cycle. Sedentary control Apc
Min/+
mice cage activity was not different from sedentary wild-type
mice at 14 weeks of age (Table 2). IL-6 overexpression
significantly increased cage activity in sedentary wild-type
mice, but had no effect on cage activity in sedentary Apc
Min/+
mice. Exercise alone did not change cage activity in Apc
Min/+
or wild-type mice. When exercise was combined with IL-6
overexpression, cage activity was significantly reduced in
both wild-type and Apc
Min/+ mice (Table 2).
a)
b)
c)
d)
e)
f)
Fig. 2 Effect of exercise and IL-6 overexpression on body weight and
muscle and fat mass in wild-type and Apc
Min/+ mice. IL-6 was overex-
pressed for 2 weeks in mice from 12 to 14 weeks of age undergoing
treadmill exercise or serving as cage control. The percent change in body
weight was calculated from values at 12 and 14 weeks of age in wild-
type (a)a n dApc
Min/+ mice (b). c The percent body weight loss correlates
to the levels of IL-6 in cage control Apc
Min/+ mice. d Changes in
quadriceps weight from systemic IL-6 overexpression. e Changes in
quadriceps weight from local IL-6 overexpression. f Changes in
epidydimal fat pad weight from 2 weeks of IL-6 overexpression. Values
are the means ± SE. Data were analyzed with two-way ANOVA.
Significance was set at p≤0.05.
†Different from all others
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spent on the RotoRod. There was no difference in RotoRod
performance between sedentary wild-type and sedentary
Apc
Min/+ mice (Table 2). Neither IL-6 overexpression nor
exercise treatments had any effect on RotoRod performance
in either wild-type or Apc
Min/+ mice (Table 2). Volitional
strength was measured using grip strength testing of all four
limbs. Interestingly, we found that 14-week sedentary
Apc
Min/+ mice had significantly greater strength compared
with wild-type mice (Table 2). While IL-6 overexpression
had no significant effects on strength in wild-type mice,
both IL-6 overexpression and exercise significantly reduced
strength in Apc
Min/+ mice. There was no interaction between
IL-6 and exercise on strength loss in Apc
Min/+ mice. Non-
exercising wild-type mice overexpressing IL-6 had signif-
icantly greater strength than control mice, and exercise had
no effect on strength, regardless of IL-6 concentration
(Table 2). In the Apc
Min/+ mice, volitional strength was
decreased by both IL-6 overexpression and by exercise
(Table 2). IL-6 overexpression in the sedentary Apc
Min/+
mice induced body weight loss and decreased volitional
strength while not affecting voluntary cage activity. IL-6
overexpression that induced Apc
Min/+ weight loss also
decreased strength without effecting neuromuscular perfor-
mance (or cage activity). Comparing the sedentary IL-6-
overexpressing Apc
Min/+ mice that lost body weight to the
exercising IL-6-overexpressing Apc
Min/+ mice that were
weight-stable, exercising mice actually had decreased cage
activity and did not improve strength despite maintaining
muscle mass.
3.4 Glucose and fatty acid metabolism
Insulin resistance often accompanies cachexia. The effect of
IL-6 overexpression on glucose and lipid metabolism was
measured in all mice at 12 and 14 weeks. Measurements
included fasting triglycerides, fasting insulin, fasting glu-
cose, and a glucose tolerance test (Fig. 3). Additionally, the
HOMA-IR index was calculated as an index of insulin
resistance [42]. At 12 weeks of age, fasting triglycerides
were increased in the cage control Apc
Min/+ mice compared
with wild-type mice, and Apc
Min/+ mice had a significantly
higher fasting glucose/insulin ratio (Table 3). Six weeks of
treadmill exercise lowered the elevated triglycerides in
Apc
Min/+ mice at 12 weeks, but did not affect the elevated
glucose/insulin ratio. At 14 weeks, neither IL-6 over-
expression nor exercise had any effect on the measured
parameters in wild-type mice. In Apc
Min/+ mice, IL-6
overexpression increased fasting triglycerides by ∼2.5-fold;
exercise reversed this increase (Fig. 3a). IL-6 overexpres-
sion induced fasting insulin levels by ∼60% in Apc
Min/+
mice; exercise also reversed this increase (Fig. 3b). Al-
though Apc
Min/+ mice had elevated fasting plasma glucose
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124 J Cachexia Sarcopenia Muscle (2012) 3:117–137compared with wild-type mice, there was no further
increase on IL-6 overexpression. Exercise did not affect
fasting glucose in Apc
Min/+ mice at 14 weeks regardless
of IL-6 overexpression (Fig. 3c). Insulin resistance was
calculated using the HOMA-IR index. At 12 weeks of age,
Apc
Min/+ mice had high HOMA-IR compared with the wild-
type mice, which was improved by exercise training
(Table 3). After 2 weeks of IL-6 overexpression, the
HOMA-IR increased by ∼50% in Apc
Min/+ mice, and this
change was attenuated by exercise (Fig. 3d). IL-6 over-
expression, which induced body weight loss in the
sedentary Apc
Min/+ mice, also increased fasting triglyceride
levels, fasting insulin levels, and the HOMA-IR index
while not affecting the already elevated fasting glucose
a)
b)
c)
d)
e)
f)
Fig. 3 Glucose metabolism after 2 weeks of IL-6 overexpression with
and without exercise intervention. At 14 weeks of age, fasting
triglycerides (a), fasting insulin (b), and fasting glucose (c)w e r e
measured after a 5-h fast. Insulin resistance was monitored by
calculating the HOMA-IR index (d) and a glucose tolerance test. In a
subset of mice (n=5–7/group), an intraperitoneal glucose tolerance test
was conducted after an overnight fast. Blood glucose was measured at
0, 15, 13, 60, 90, and 120 min. Insulin area under the curve (AUC)( e)
and glucose AUC (f) were calculated from values obtained during the
glucose tolerance test. Values are the means ± SE. Data were analyzed
with two-way ANOVA within each genotype. Significance was set at
p≤0.05. *Interaction between IL-6 and cage control
J Cachexia Sarcopenia Muscle (2012) 3:117–137 125levels. When comparing the sedentary IL-6-overexpressing
Apc
Min/+ mice that lost body weight to the exercising IL-6-
overexpressing Apc
Min/+ mice that were weight-stable,
exercise reduced fasting triglycerides, fasting insulin, and
the HOMA-IR index.
To further investigate insulin resistance, a glucose
tolerance test was administered to a subset of mice.
After 6 weeks of exercise, there was no difference in
insulin area under the curve (AUC) between wild-type
and Apc
Min/+ mice (BL-6 CC=87±7 AUC; BL-6 Ex=88±
4 AUC; Min CC=98±5 AUC; Min Ex=99±7 AUC).
There was also no difference in glucose AUC at 12 weeks
of age regardless of genotype or exercise (BL-6 CC=
15,359±1,969 AUC; BL-6 Ex=16,097±2,978 AUC; Min
CC =20,672±3,026 AUC; Min Ex=18,126±2,062 AUC).
InsulinandglucoseAUCwerealsocalculatedafter2weeksof
IL-6 overexpression (Fig. 3e, f). There was a main effect for
exercise to decrease the insulin AUC in the Apc
Min/+ mice
regardless of IL-6 treatment (Fig. 3e). Glucose AUC was
unchanged by IL-6 or exercise treatments in both wild-type
and Apc
Min/+ mice (Fig. 3f). Thus, while altered glucose
clearance is associated with cancer in Apc
Min/+ mice, it
appears to at least initially be independent of IL-6-induced
muscle wasting.
IL-6 overexpression increased fasting triglyceride
levels ∼2.5-fold in Apc
Min/+ mice, which was reversed by
exercise (Fig. 3a). We next examined a subset of mice out to
20 weeks of age to determine the correlation between fasting
triglyceride levels and the development of cachexia. At
20 weeks of age, mice were separated by the degree of body
weight loss into mild or severe categories of cachexia.
Triglycerides were only increased in the Apc
Min/+ mice that
developed severe cachexia (Fig. 4a). Additionally, this
increase in triglyceride levels was apparent at 14 weeks of
age, which was prior to body weight loss in these mice.
Triglycerides continued to increase as body weight loss
progressed. The level of circulating triglycerides was also
significantly correlated with the percentage of body weight
loss (Fig. 4b) and with circulating IL-6 levels (Fig. 4c).
These data demonstrate that elevated fasting triglycerides are
a useful predictor of risk for cachexia in Apc
Min/+ mice, and
future work is needed to determine whether they are also
useful for predicting cachexia in cancer patients.
Plasma glycerol levels, which are indicative of the rate of
lipolysis, were significantly higher in sedentary control
Apc
Min/+ mice compared with sedentary control wild-type
mice (Fig. 5a). There was a main effect of exercise to
decrease fasting glycerol levels in wild-type mice regardless
of IL-6 overexpression. In Apc
Min/+ mice, there was no effect
of exercise or IL-6 on glycerol levels (Fig. 6a). In cage
control Apc
Min/+ mice, plasma glycerol was significantly
correlated with the percent change in body weight, but this
correlation was lost with exercise training (Fig. 5b). Al-
though there appears to be considerable variability in
response, weight loss in sedentary Apc
Min/+ mice is related
to an increased rate of lipolysis. However, the preventative
effect of exercise on IL-6-induced body weight loss is
apparently not related to changes in the rate of lipolysis. This
corresponds to the inability of exercise to prevent loss of
epididymal fat pad mass (Fig. 2f).
3.5 Circulating adiponectin and leptin
To assess their role in the progression of cachexia, we
measured the circulating levels of adiponectin and leptin.
Adiponectin, a hormone secreted from fat, modulates
several metabolic processes, including glucose homeostasis
and fatty acid catabolism. Adiponectin levels were de-
creased in sedentary control Apc
Min/+ mice compared with
sedentary control wild-type mice. In both Apc
Min/+ and
wild-type mice, there was a main effect for IL-6 over-
expression to decrease adiponectin levels, regardless of
Table 3 Effect of exercise on glucose metabolism in 12-week-old wild-type and Apc
Min/+ mice
C57BL/6 Apc
Min/+
Cage control Exercise Cage control Exercise
N 23 25 27 26
Fasting glucose (mg/dL) 108.5±6.6 117.8±6.1 140.4±5.2
a 137.8±5.4
a
Fasting triglycerides (mg/dL) 72.7±4.3 90.2±8.2 104.9±10.2
b 93.5±10.7
Fasting insulin (ng/mL) 0.46±0.08 0.52±0.05 0.48±0.02 0.44±0.02
Glucose/insulin 194.8±45.7 191.9±34.7 305.4±15.7
a 321.6±26.1
a
HOMA 3.1±0.1 3.2±0.2 4.2±0.3
a 3.5±0.2
a
Measurements were taken prior to 2 weeks of IL-6 overexpression. Glucose was taken after an overnight fast using a handheld glucometer and blood
takenfromthetailvein.Triglyceridesandinsulinweremeasuredaftera5-hfastwithbloodtakenfromthetailvein.Valuesarethemeans±SE.Datawere
analyzed with two-way ANOVA. Significance was set at p≤0.05
aMain effect of genotype
bInteraction between genotype and exercise
126 J Cachexia Sarcopenia Muscle (2012) 3:117–137exercise. Exercise had no effect on the level of circulating
adiponectin (Fig. 5c). Leptin levels were not different
between sedentary control Apc
Min/+ mice compared with
sedentary control wild-type mice. Wild-type and Apc
Min/+
mice leptin levels responded differentially to exercise and
IL-6 overexpression. There was a main effect of exercise to
decrease circulating leptin levels regardless of IL-6 treat-
ment. In Apc
Min/+ mice, there was a main effect of IL-6
overexpression to increase leptin levels regardless of
exercise (Fig. 5d). While fat mass loss proceeds with the
development of cachexia, the relationship of circulating
adiponectin and leptin to body weight loss remains to be
established.
3.6 Skeletal muscle oxidative capacity
To determine whether IL-6 overexpression altered the
quadriceps muscle adaptive response to the exercise training,
wemeasuredcytochromeCandCOXIVproteinexpressionas
an indicator of muscle oxidative capacity. Systemic IL-6
overexpression had no effect on the protein expression of
cytochrome C and COX IV in Apc
Min/+ mouse (Fig. 6b);
however, systemic IL-6 caused a decrease in protein
expression of cytochrome C and COX IV in wild-type mice
(Fig. 6a). There was a main effect of exercise to increase
cytochrome C and COX IV protein expression regardless of
IL-6 overexpression in both the wild-type (Fig. 6a)a n d
Apc
Min/+ mice (Fig. 6b).
WealsoexaminedtheeffectsofbothlocalandsystemicIL-
6 overexpression on quadriceps muscle oxidative capacity
with and without exercise training. The quadriceps muscle
from Apc
Min/+ mice undergoing both systemic and local IL-6
overexpression (Fig. 6b, d) also demonstrated a significant
main effect of exercise to increase cytochrome C and
COXIV protein expression (Fig. 6d); however, the overall
exercise induction appeared attenuated when compared with
muscle exposed to increased systemic IL-6 only. In the IL-6-
overexpressing quadriceps muscle from wild-type mice,
exercise significantly induced COX IV, but has little effect
on cytochrome C protein expression (Fig. 6c).
3.7 Skeletal muscle inflammation
To determine whether exercise could alter muscle inflam-
matory signaling induced by IL-6 overexpression, we
examined STAT3 and NFkB signaling. Systemic IL-6
overexpression had no effect on total STAT3 protein
expression in either wild-type (p=0.22) or Apc
Min/+ mice
(p=0.75); similarly, total NFkB protein expression was not
altered in either wild-type (p=0.68) or Apc
Min/+ mice (p=
0.48, data not shown). Systemic Il-6 overexpression
induced the ratio of phosphorylated to total STAT twofold
in wild-type mice (Fig. 7a) and fourfold in Apc
Min/+ mice
(Fig. 7b). The activation of NFkB signaling, the ratio of
phosphorylated to total, was increased fivefold in wild-type
muscle and 38-fold in Apc
Min/+ mouse muscle by systemic
IL-6 overexpression. The systemic IL-6 induction of muscle
inflammatory signaling was not attenuated by exercise
training in both the wild-type and Apc
Min/+ mice (Fig. 7a, b),
demonstrating that exercise can benefit muscle mass indepen-
dent of decreased STAT and NFkB signaling.
Fig. 4 Circulating triglycerides are increased with severity of cancer
cachexia. Fasting triglycerides were measured at 10, 14, and 20 weeks of
age in Apc
Min/+ mice and data stratified by cachexia severity. a Fasting
triglycerides measured at 10, 14, and 20 weeks from mild and severely
cachectic Apc
Min/+ mice. Samples were taken from the same mice at
three different ages. b Circulating triglycerides correlate with percent
body weight loss from peak body weight to body weight at 20 weeks
(p=0.01).c Circulating triglycerides correlate with plasma IL-6 levels at
20 weeks of age (p=0.001). Values are the means ± SE. Data were
analyzed with repeated measures two-way ANOVA and Pearson’s
correlation. Significance was set at p≤0.05
J Cachexia Sarcopenia Muscle (2012) 3:117–137 127The quadriceps muscles subjected to both local and
systemic IL-6 overexpression with or without exercise
training were also examined. Total STAT3 (wild type: p=
0.52; Apc
Min/+: p=0.08) or total NFkB (wild type: p=0.75;
Apc
Min/+: p=0.11) protein expression was not significantly
changed by local IL-6 overexpression with or without
exercise (data not shown). There was a significant main
effect of local IL-6 overexpression to induce STAT3 and
NFkB activation in wild-type muscle (Fig. 7c) and Apc
Min/+
mice (Fig. 7d) regardless of exercise. Exercise training did
not significantly attenuate or accentuate the induction of
inflammatory signaling in Apc
Min/+ mice.
3.8 Skeletal muscle metabolism
To determine whether exercise training would alter IL-6-
induced regulation of muscle metabolism, we examined
adenosine monophosphate-activated protein kinase (AMPK;
T172)andproteinkinaseB(Akt);(T308)activation.Systemic
IL-6 overexpression in Apc
Min/+ mice increased muscle
AMPK activation threefold; exercise training significantly
attenuated this increase (Fig. 8b). There was no effect of
systemic IL-6 overexpression on AKT activation in Apc
Min/+
mice, but exercise training has a significant main effect on
AKT activation regardless of IL-6 overexpression (Fig. 8b).
In the wild-type mouse, neither IL-6 overexpression nor
exercise training significantly altered AMPK activation
(Fig. 8a). There was no effect of IL-6 or exercise on total
AMPK protein expression levels in wild-type or Apc
Min/+
mice (data not shown). Similarly, total AKT protein
expression was not affected by IL-6 or exercise in wild-type
or Apc
Min/+ mice (data not shown).
In muscle subjected to both local and systemic IL-6
overexpression, there was a trend (p=0.06) for IL-6 to
increase AMPK activation in wild-type mice (Fig. 8c). In
Apc
Min/+ mice, there was a main effect of exercise to reduce
AMPK activation regardless of IL-6 expression (Fig. 8d),
which was due to a significant increase in total AMPK
a)
b)
c)
d)
Fig. 5 Lipid metabolism after 2 weeks of IL-6 overexpression with and
without exercise training. a At 14 weeks of age, plasma glycerol was
measured in a subset of mice (n=5) after a 5-h fast. b Fasting glycerol
levels in cage control Apc
Min/+ mice (circles) correlated with percent
change in body weight (R
2=0.87, p<0.001). Fasting glycerol levels in
exercised Apc
Min/+ mice (triangles) were not correlated with percent
change in body weight (R
2=0.18, p=0.26). Plasma concentrations of
adiponectin (c) and leptin (d) were measured after 2 weeks of IL-6
overexpression. Mice were fasted for 5 h prior to the collection of
plasma samples at the time of killing. Values are the means±SE. Data
were analyzed with two-way ANOVA. Pearson’s correlation analysis
was performed to compare percent change in body weight with glycerol
levels in the Apc
Min/+ mice. Significance was set at p≤0.05
128 J Cachexia Sarcopenia Muscle (2012) 3:117–137protein expression with exercise (p=0.006). While local IL-6
overexpression induced muscle AKT activity in wild-type
mice (Fig. 8c), and this induction was attenuated by exercise
training, this response was not significant in the Apc
Min/+
mice due to variability in the activation of AKTwith exercise
(Fig. 8d).
4 Discussion
Exercisehasbeenshowntoaidinthepreventionofcancerand
is thought to be of therapeutic value in slowing the
progression or even preventing the development of cachexia.
Although many studies have examined the effects of aerobic
exercise training on the development and progression of
cancer [11, 41, 45], the direct examination of exercise on the
prevention of muscle loss and progression of cachexia was
often not the primary outcome analyzed by these studies.
Several studies suggest the use of exercise training to
ameliorate muscle wasting in conditions of cachexia, as
reviewed by Zinna and Yarasheski [44], but the underlying
mechanisms of the protective effects of exercise remains
poorly defined. To our knowledge, our study presented here
is the first mechanistic examination of controlled moderate-
intensity aerobic exercise on systemic and muscle metabolic
changes that normally occur with the progression of
cachexia. Additionally, this study was conducted under
conditions where systemic inflammation was maintained.
While our study confirms that regular treadmill exercise can
reduce the intestinal polyp burden in Apc
Min/+ mice, we
demonstrate the novel finding that moderate treadmill
exercise is effective in preventing IL-6-induced body weight
and muscle loss in Apc
Min/+ mice. The exercise-induced
attenuation of cachexia was associated with improved insulin
a)
b)
BL6 CC BL6 CC+IL6 BL6 Ex BL6 Ex+IL6
Cytochrome C
COX IV
Ponceau
Cytochrome C
COX IV
Min CC Min CC+IL6 Min Ex Min Ex+IL6
Ponceau
Fig. 6 Effect of local and systemic IL-6 overexpression and exercise on
muscle oxidative capacity. To measure the effect of systemic IL-6
overexpression, the relative protein expression of cytochrome C and
COX IV was measured in the wild-type left quadriceps muscle (a)a n d
the Apc
Min/+ left quadriceps muscle (b). The effects of local IL-6
overexpression on protein expression of cytochrome c and COX IV
were measured in the right quadriceps muscle of wild-type (c)a n d
Apc
Min/+ (d) mice. All data were normalized to cage control (CC).
Values are the means±SE. Data were analyzed with two-way ANOVA.
Significance was set at p≤0.05. *Effect of IL-6 within cage control
J Cachexia Sarcopenia Muscle (2012) 3:117–137 129sensitivity and glucose metabolism despite high circulating
IL-6 levels. The exercise attenuation of muscle mass loss
was associated with an increased muscle oxidative metabolic
capacity, an attenuation of IL-6-induced muscle AMPK
activation, and increased muscle AKTactivation. All of these
exercise-induced changes that benefited muscle mass reten-
tion occurred without a reduction in muscle inflammatory
signaling. Overall, exercise-induced improvements in insulin
resistance, lipid metabolism, and food consumption appear
important for muscle and body weight maintenance in the
Apc
Min/+ mouse.
The current study confirms that systemic IL-6 overexpres-
sion is sufficient to decrease body weight and muscle mass in
sedentary Apc
Min/+ mice, as previously reported [5, 41].
However, this current study extends prior observations by
demonstrating that only 2 weeks of IL-6 overexpression in a
younger, weight-stable, non-cachectic Apc
Min/+ mouse can
induce significant muscle and body weight loss. Prior studies
with Apc
Min/+ mice had examined 4 weeks of IL-6 over-
expression, starting at a more advanced 16 weeks of age [5,
41]. Although muscle mass and body weight were maintained
in exercising Apc
Min/+ mice despite high circulating IL-6
levels, exercise was not able to prevent epididymal fat loss.
This finding suggests that initial preservation of fat may not
be required to preserve body weight and muscle mass during
the onset of cachexia. Decreased physical activity and
increased fatigue occur with cancer cachexia [19, 20];
however, we did not find decreased cage activity to be
associated with IL-6-induced body weight loss in Apc
Min/+
mice. This is interesting because we have reported that
Apc
Min/+ mouse voluntary wheel running distance is inversely
correlated with the degree of cachexia [12], and hindlimb
muscle oxidative capacity is severely repressed in late-stage
cachexia [18]. Thus, our current data suggest that this loss of
oxidative capacity may not be due to a decreased cage
activity. We did find that the combination of IL-6 over-
expression and exercise, which prevented cachexia, also
repressed cage activity. However, it is a possibility that the
decreased cage activity was associated with fatigue, related to
the daily exercise protocol. Cancer patients’ daily activity
c)
d)
BL6 CC BL6 CC+ IL6 BL6 Ex BL6 Ex+ IL6
Cytochrome C
COX IV
Ponceau
Cytochrome C
COX IV
Min CC Min CC+ IL6 Min Ex Min Ex+ IL6
Ponceau
Fig. 6 (continued)
130 J Cachexia Sarcopenia Muscle (2012) 3:117–137levels have been reported comparable to healthy activity
levels, but cancer patients also had significantly reduced
spontaneous activity [45]. In support of repressed volitional
effort, we found that exercise, despite positive effects on body
weight and muscle mass, did not improve IL-6-suppressed
v o l u n t a r yg r i ps t r e n g t hi nApc
Min/+ mouse. However, we
found no change in performance on the RotoRod, similar to
our previous results with cachectic mice [41], which we
interpret to mean muscle neuromuscular control was main-
tained during cachexia. Additionally, exercising Apc
Min/+
mice were able to complete all moderate-intensity treadmill
exercise sessions. Since the decreased cage activity was
found in mice that did not develop cachexia, it appears that
the decreased cage activity and volitional strength could be
associated with centrally mediated mechanisms that induce
fatigue and possibly related to IL-6 overexpression, However,
these fatigue-related changes were independent of the
processes that preserve body weight and muscle mass, but
would certainly impact life quality.
Insulin resistance is a hallmark of cachexia [21, 22, 46,
47], so improved insulin sensitivity may be one mechanism
by which exercise could protect against cachexia. Besides
inducing weight loss, IL-6 overexpression in Apc
Min/+ mouse
increased fasting triglycerides, fasting insulin, and the
HOMA index, which are all indicative of increased insulin
resistance. Regular moderate-intensity treadmill exercise was
able to normalize all of these parameters. Exercise has well-
documented effects on insulin sensitivity and glucose
clearance, even in obese and type 2 diabetic patients [48–
50]. Interestingly, the exercise-induced changes in glucose
metabolism occurred without a reduction in circulating IL-6
concentration. Although chronically elevated IL-6 levels
have been associated with increased glucose uptake [51]
and insulin resistance, the relationship of IL-6 with insulin
resistance is still equivocal [52–54]. The administration of
metformin and rosiglitazone, insulin sensitizers, to cachectic
rodents with high IL-6 levels can decrease tumor growth and
markers of muscle proteolysis [22, 23]. Triglyceride levels
Min CC Min CC+ IL6 Min Ex Min Ex+IL6
P-STAT3 (Y705) 
P-NFkB p65 (S468)
Ponceau
a)
b)
BL6 CC BL6CC +IL-6 BL6 Ex BL6 Ex+IL6
P-STAT (Y705) 
P-NFkB p65 (S468)
Ponceau
Fig. 7 Effect of local and systemic IL-6 overexpression and exercise on
STAT3andNFkBmarkersofmuscleinflammation.Tomeasuretheeffect
of systemic IL-6 overexpression, the relative protein expression of p-
STAT3(Y705) and p-NFkB(S468) was measured and normalized to
levels of total STAT3 and NFkB in the wild-type left quadriceps muscle
(a) and the Apc
Min/+ left quadriceps muscle (b). The effects of local IL-6
overexpression on the protein expression of p-STAT3(Y705) and p-
NFkB(S468) were measured and normalized to the levels of total
STAT3 and NFkB in the wild-type right quadriceps muscle (c) and the
Apc
Min/+ right quadriceps muscle (d). All data were normalized to cage
control (CC). Values are the means ± SE. Data were analyzed with two-
way ANOVA. Significance was set at p≤0.05
J Cachexia Sarcopenia Muscle (2012) 3:117–137 131are commonly elevated in cachexia [55, 56], but little is
understood regarding their role in the development and
progression of the disease. As in our study, exercise has been
shown to reduce triglyceride levels in cachectic tumor-
bearing rats after 8 weeks of exercise training [57]. However,
we extend these findings to show in the Apc
Min/+ mouse that
elevated fasting triglyceride levels are predictive of weight
loss, being elevated earlier and to a greater extent in mice
that eventually develop severe cachexia. Early increases in
triglycerides have been noted in other models of cancer
cachexia as well, but the implication to use them as a
predictive measure of cachexia has not been addressed [58].
We also found that fasting triglyceride levels were strongly
correlated with the degree of body weight loss and the
circulating IL-6 concentration. Adiponectin is an insulin-
sensitizing adipokine and contributes to the regulation of
muscle insulin resistance and oxidative capacity [59]. While
IL-6 overexpression reduced the circulating levels of adipo-
nectin, the preventative effect of exercise on weight loss was
not correlated with the altered levels of these hormones. The
disconnect between the IL-6 reduction in adiponectin and the
improved insulin sensitivity in exercising mice requires
further investigation, but could be attributed to exercise-
induced adiponectin-independent effects on metabolism.
Skeletal muscle oxidative capacity and mitochondrial
function can influence muscle glucose uptake and has been
associated with insulin resistance and type 2 diabetes [60,
61]. Additionally, altered mitochondria content is also
related to a diminished ability of the muscle to efficiently
oxidize fatty acids and has been suggest to decrease muscle
metabolic flexibility [62]. Decreased skeletal muscle oxi-
dative capacity has been reported with many wasting
conditions [63–66], and we have found that both red and
white hindlimb muscles from the severely cachectic Apc
Min/+
mice have reduced mitochondrial content and oxidative
protein expression. The loss of muscle oxidative capacity
in the later stages of cachexia [18] also corresponds with
severe insulin resistance, as seen by the inability to clear
glucose during a glucose tolerance test late in cachexia [67].
In the present study, IL-6 overexpression for 2 weeks in
Apc
Min/+ mice that were weight-stable at the beginning of the
IL-6 treatment did not suppress quadriceps muscle oxidative
protein expression. This finding confirms our earlier obser-
vations that oxidative protein loss occurs later in the
d)
c)
P-STAT (Y705)
Ponceau
P-NFkB p65 (S468)
Min CC Min CC+ IL6 Min Ex Min Ex+IL6
Ponceau
BL6 CC BL6CC +IL-6 BL6 Ex BL6 Ex+IL6
P-STAT (Y705) 
P-NFkB p65 (S468)
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Min/+ mice since mice had only
lost approximately 8% of their body weight at the end of the
2-week treatment. These observations further demonstrate
that the initial loss of muscle mass and the corresponding
increase in insulin resistance at the onset of cachexia are
independent of muscle oxidative protein loss. Related to
muscle plasticity with exercise, our study confirms that
tumor-bearing mice can improve skeletal muscle oxidative
capacity and further extends these findings to demonstrate
that oxidative changes can occur while circulating IL-6 levels
are maintained at chronically high levels. Improvements in
oxidative capacity are closely linked to improvements in
insulin resistance [68, 69] and could be a mechanism through
which exercise is working to improve insulin sensitivity
during the onset of cachexia.
Improvements in insulin resistance and attenuation of the
cachectic condition may also be explained by alterations in
muscle metabolic signaling related to insulin and energy
status. Muscle anabolic signaling induced by insulin and
insulin-like growth factor 1 occurs through the activation of
the PI3K/AKT/mTOR pathway. Activated AKT can also
decrease the transcription of genes involved in ATP-
dependent ubiquitin proteasome degradation of muscle
protein [70]. AMPK is activated in muscle by a decrease in
available energy and also contraction [71] AMPK activation
promotes several cellular processes including the inhibition
of protein synthesis through mTOR inhibition, increased
glucose uptake, increased protein degradation, and induction
of mitochondrial biogenesis [71]. Additionally, the chronic
elevation of IL-6 has been shown to stimulate AMPK [72,
73]. In the Apc
Min/+ mouse, AMPK and AKT activation are
both increased with the progression of cachexia, and their
activation is associated with decreased muscle mass [74].
However, at the onset of cachexia or during pre-cachexia,
a)
b)
P-AKT (T308)
P-AMPK (T172)
Ponceau
Min CC Min CC+ IL6 Min Ex Min Ex+IL6
P-AKT (T308)
P-AMPK (T172)
Ponceau
BL6 CC BL6CC +IL6 BL6 Ex BL6 Ex+IL-6
Fig. 8 Effect of local and systemic IL-6 overexpression and exercise
on AKTand AMPK markers of energy status. To measure the effect of
systemic IL-6 overexpression, the relative protein expression of
phosphorylated (T172) AMPK and phosphorylated (T308) AKT was
measured and normalized to the levels of total AMPK and AKT in the
wild-type left quadriceps muscle (a) and the Apc
Min/+ left quadriceps
muscle (b). The effects of local IL-6 overexpression on the protein
expression of phosphorylated (T172) AMPK and phosphorylated
(T308) AKT were measured and normalized to the levels of total
AMPK and AKT in the wild-type right quadriceps muscle (c) and the
Apc
Min/+ right quadriceps muscle (d). Values are the means±SE. Data
were analyzed with two-way ANOVA. Significance was set at p≤
0.05. *Effect of exercise within IL-6
J Cachexia Sarcopenia Muscle (2012) 3:117–137 133neither AKT nor AMPK is activated [74]. Furthermore,
attenuation of further body weight and muscle mass loss
during the progression of cachexia by systemic administration
of an IL-6r antibody, a potential therapeutic target for
treatment of cancers [75], to cachectic Apc
Min/+ mice also
significantly decreases AKT and AMPK activation [74]. This
IL-6r antibody decrease in AMPK and AKT activation was
also associated with a reduction of STAT3 phosphorylation.
Interestingly, regular moderate exercise was able to attenuate
IL-6-increased phosphorylation of AMPK independent of any
reduction in the increased level of muscle STATsignaling. IL-
6 overexpression induced quadriceps muscle inflammatory
signaling related to STAT and NFkB activation that was
not attenuated by exercise training. Thus, exercise may be
acting through alternative pathways that can circumvent
inflammation-induced muscle mass loss. Exercise may be
decreasing the activation of AMPK through improved
oxidative capacity, which may be relieving energy stress of
the cells; however, this still requires further investigation.
While preventing or slowingloss of skeletal muscle massis
a widely acknowledgedgoal for the treatmentofcachexia,loss
of adipose tissue mass and its impact on cachexia progression
is less well understood.Adipose tissue has thepotential to alter
cachexia progression through several mechanisms, including
its role in fuel supply, thermal regulation, organ protection,
insulin resistance, as a source of inflammation, and as a source
of adipokines. A study by Das et al. [76] reported that when
white adipose tissue was maintained through an ablation of
adipose triglyceride lipase, muscle mass was maintained. In
the present study, exercise prevented skeletal muscle mass
loss without affecting epididymal fat mass loss. IL-6 has been
reported to activate lipolysis in adipose tissue [77]. We
examined lipolysis by measuring plasma glycerol, which is a
reliable indicator of lipolysis and is increased in cachectic
patients [78]. Consistent with previous reports, wild-type
mice had decreased fasting plasma glycerol levels in response
to exercise training [79, 80], which correlates with the
exercise-induced decrease in fat mass in these mice.
However, in non-exercising Apc
Min/+ mice, plasma glycerol
levels were not associated with body weight loss. While
glycerol was increased in the pre-cachectic Apc
Min/+ mouse
compared with wild-type mice, the lipolysis rate was related
to cancer progression rather than cachexia.
IL-6 overexpression decreased the circulating levels of the
adipokine leptin in Apc
Min/+ mice regardless of exercise,
which corresponded with fat mass loss. Leptin levels have
P-AMPK (T172)
P-AKT (T308)
Ponceau
BL6 CC BL6CC +IL6 BL6 Ex BL6 Ex+IL-6 c)
d)
P-AMPK (T172)
P-AKT (T308)
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134 J Cachexia Sarcopenia Muscle (2012) 3:117–137been extensively examined in cachexia [81–83]. Smiechowska
et al. [84] showed that patients with cachexia had decreased
leptin levels, cancer patients without weight loss had
increased leptin compared with controls, and that plasma
leptin correlated with insulin resistance. Leptin is well
acknowledged as a factor in appetite control. In the current
study, IL-6 decreased food consumption in both the wild-type
mice and the Apc
Min/+ mice, but only the Apc
Min/+ mice lost
body weight and leptin was not suppressed by IL-6
expression in the wild-type mice, suggesting that IL-6 alone
does not regulate leptin levels. Furthermore, food consump-
tion was not significantly correlated with body weight loss in
cage control mice overexpressing IL-6. Since food consump-
tion varied greatly by animal, it was not possible to strongly
link altered food consumption and body weight loss in the
Apc
Min/+ mouse; future research with a pair feeding design
might be better able to demonstrate the effect of food
consumption on energy balance and the progression of
cachexia in Apc
Min/+ mouse.
Thecurrentstudy’smethodofIL-6ov erex pres sionusingin
vivo quadriceps muscle electroporation allowed the novel
comparison of systemic IL-6 overexpression, the non-
electroporated quadriceps, with the electroporated quadriceps
subjected tobothlocal and systemicIL-6 overexpression. Our
prior studies have only examined non-electroporated muscle
subjected to systemic IL-6 overexpression since we have
never found an induction of IL-6 mRNA in Apc
Min/+ mouse
hindlimb muscle [18]. Hence, local overexpression does not
appear physiological to our condition of cachexia, but serves
as an interesting secondary observation. Although exercising
Apc
Min/+ mice maintained quadriceps muscle mass when
subjected to systemic IL-6 overexpression, exercise was not
able to preserve quadriceps muscle mass directly over-
expressing IL-6. There was a significant effect of local IL-6
overexpression regardless of exercise to increase cytochrome
C protein expression, increase STAT activation, and increase
NFkB activation. There was no effect of local IL-6
expression on COXIV protein expression, AMPK activation,
or AKT activation. This differed from systemic IL-6 over-
expression only in that cytochrome C protein was not
induced and AMPK activation was induced. These were all
main effects of local IL-6 overexpression regardless of the
exercise treatment. The exercise-induced increase in COXIV
protein expression was attenuated in the local IL-6-
overexpressing quadriceps muscle when compared with
systemic IL-6 overexpression only (approximately 1.5-fold
versus 9-fold, respectively).
In conclusion, we have shown that exercise effectively
prevents loss of body weight and muscle mass even in the
presence of high circulating IL-6 levels. Although the
protective mechanisms of exercise need further study, our
data support the effect of exercise on insulin resistance as a
potential mechanism that could be mediated through im-
provedoxidative capacity, AKTsignaling,and energysensing
(decreased AMPK) without altering muscle inflammatory
signaling. We have shown that Apc
Min/+ mice with moderate
cachexia have altered glucose and lipid metabolism. Our
study also points to the need for further understanding on the
role of adipose tissue loss and changes in plasma adipokines
during the initiation and progression of cachexia. Further
research is necessary to determine whether measurement of
plasma triglyceride levels may be useful for predicting risk
and assessing response to therapy for cancer cachexia.
Acknowledgments We would like to acknowledge the technical
assistance of Tia Davis. The authors of this manuscript certify that
they comply with the ethical guidelines for authorship and publishing
in the Journal of Cachexia, Sarcopenia and Muscle [85]. The project
was funded by a grant to James A. Carson (NIH/NCI 1 RO1
CA121249-01).
Conflict of interest The authors declare that they have no conflict of
interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Deans C, Wigmore SJ. Systemic inflammation, cachexia and
prognosis in patients with cancer. Curr Opin Clin Nutr Metab
Care. 2005;8:265–9.
2. Tisdale MJ. The ‘cancer cachectic factor’. Support Care Cancer.
2003;11:73–8.
3. Carson JA, Baltgalvis KA. Interleukin 6 as a key regulator of
muscle mass during cachexia. Exerc Sport Sci Rev. 2010;38:168–
76.
4. Moser AR, Pitot HC, Dove WF. A dominant mutation that
predisposes to multiple intestinal neoplasia in the mouse. Science.
1990;247:322–4.
5. Baltgalvis KA, Berger FG, Pena MM et al. Interleukin-6 and
cachexia in Apc
Min/+ mice. Am J Physiol Regul Integr Comp
Physiol. 2008;294:R393–401.
6. Haydon AM, Macinnis RJ, English DR et al. Effect of physical
activity and body size on survival after diagnosis with colorectal
cancer. Gut. 2006;55:62–7.
7. Thompson D, Markovitch D, Betts JA et al. Time-course of
changes in inflammatory markers during a 6-month exercise
intervention in sedentary middle-aged men: a randomized-
controlled trial. J Appl Physiol. 2010;108:769–79.
8. Fischer CP, Berntsen A, Perstrup LB et al. Plasma levels of
interleukin-6 and C-reactive protein are associated with physical
inactivity independent of obesity. Scand J Med Sci Sports.
2007;17:580–7.
9. Mathur N, Pedersen BK. Exercise as a mean to control low-grade
systemic inflammation. Mediators Inflamm. 2008;2008:109502.
10. Baltgalvis KA, Berger FG, Pena MM et al. The interaction of a
high-fat diet and regular moderate intensity exercise on intestinal
polyp development in Apc
Min/+ mice. Cancer Prev Res (Phila Pa).
2009;2:641–9.
J Cachexia Sarcopenia Muscle (2012) 3:117–137 13511. Baltgalvis KA, Berger FG, Pena MM, et al. Effect of exercise on
biological pathways in Apc
Min/+ mouse intestinal polyps. J Appl
Physiol. 2008;104:1137–43.
12. Baltgalvis KA, Berger FG, Pena MM et al. Activity level,
apoptosis, and development of cachexia in Apc
Min/+ mice. J Appl
Physiol. 2010;109:1155–61.
13. Colbert LH, Mai V, Tooze JA et al. Negative energy balance
induced by voluntary wheel running inhibits polyp development
in APC
Min mice. Carcinogenesis. 2006;27:2103–7.
14. Bacurau RF, Belmonte MA, Seelaender MC et al. Effect of a
moderate intensity exercise training protocol on the metabolism of
macrophages and lymphocytes oftumour-bearing rats. CellBiochem
Funct. 2000;18:249–58.
15. Basterfield L, Reul JM, Mathers JC. Impact of physical activity on
intestinal cancer development in mice. J Nutr. 2005;135:3002S–
8S.
16. Reddy BS, Sugie S, Lowenfels A. Effect of voluntary exercise on
azoxymethane-induced colon carcinogenesis in male F344 rats.
Cancer Res. 1988;48:7079–81.
17. Evans WJ, Morley JE, Argiles J et al. Cachexia: a new definition.
Clin Nutr. 2008;27:793–9.
18. White JP, Baltgalvis KA, Puppa MJ et al. Muscle oxidative
capacity during IL-6 dependent cancer cachexia. Am J Physiol
Regul Integr Comp Physiol. 2011;300:R201–11.
19. Maddocks M, Byrne A, Johnson CD et al. Physical activity level
as an outcome measure for use in cancer cachexia trials: a
feasibility study. Support Care Cancer. 2010;18:1539–44.
20. Mustian KM, Morrow GR, Carroll JK et al. Integrative non-
pharmacologic behavioral interventions for the management of
cancer-related fatigue. Oncologist. 2007;12:52–67.
21. Dodesini AR, Benedini S, Terruzzi I et al. Protein, glucose and
lipid metabolism in the cancer cachexia: a preliminary report. Acta
Oncol. 2007;46:118–20.
22. Asp ML, Tian M, Wendel AA et al. Evidence for the contribution
of insulin resistance to the development of cachexia in tumor-
bearing mice. Int J Cancer. 2010;126:756–63.
23. Tomimoto A, Endo H, Sugiyama M et al. Metformin suppresses
intestinal polyp growth in Apc
Min/+ mice. Cancer Sci. 2008;99:
2136–41.
24. Bradley RL, Jeon JY, Liu FF et al. Voluntary exercise improves
insulin sensitivity and adipose tissue inflammation in diet-induced
obese mice. Am J Physiol Endocrinol Metab. 2008;295:E586–94.
25. Duncan GE, Perri MG, Theriague DW et al. Exercise training,
without weight loss, increases insulin sensitivity and postheparin
plasma lipase activity in previously sedentary adults. Diabetes
Care. 2003;26:557–62.
26. James DE, Burleigh KM, Kraegen EW et al. Effect of acute
exercise and prolonged training on insulin response to intravenous
glucose in vivo in rat. J Appl Physiol. 1983;55:1660–4.
27. James DE, Kraegen EW, Chisholm DJ. Effect of exercise training
on whole-body insulin sensitivity and responsiveness. J Appl
Physiol. 1984;56:1217–22.
28. Houmard JA, Shaw CD, Hickey MS et al. Effect of short-
term exercise training on insulin-stimulated PI 3-kinase
activity in human skeletal muscle. Am J Physiol. 1999;277:
E1055–60.
29. Smith JK, Dykes R, Douglas JE et al. Long-term exercise and
atherogenic activity of blood mononuclear cells in persons at
risk of developing ischemic heart disease. JAMA. 1999;281:
1722–7.
30. Goldhammer E, Tanchilevitch A, Maor I et al. Exercise training
modulates cytokines activity in coronary heart disease patients. Int
J Cardiol. 2005;100:93–9.
31. Mattusch F, Dufaux B, Heine O et al. Reduction of the plasma
concentration of C-reactive protein following nine&newnbsp;
months of endurance training. Int J Sports Med. 2000;21:21–4.
32. Kondo T, Kobayashi I, Murakami M. Effect of exercise on
circulating adipokine levels in obese young women. Endocr J.
2006;53:189–95.
33. Iwase S, Murakami T, Saito Y et al. Steep elevation of blood
interleukin-6 (IL-6) associated only with late stages of cachexia in
cancer patients. Eur Cytokine Netw. 2004;15:312–6.
34. Strassmann G, Fong M, Kenny JS et al. Evidence for the
involvement of interleukin 6 in experimental cancer cachexia. J
Clin Invest. 1992;89:1681–4.
35. Heinrich PC, Behrmann I, Haan S et al. Principles of interleukin
(IL)-6-type cytokine signalling and its regulation. Biochem J.
2003;374:1–20.
36. Pradhan AD, Manson JE, Rifai N et al. C-reactive protein,
interleukin 6, and risk of developing type 2 diabetes mellitus.
JAMA. 2001;286:327–34.
37. Tsigos C, Papanicolaou DA, Kyrou I et al. Dose-dependent effects
of recombinant human interleukin-6 on glucose regulation. J Clin
Endocrinol Metab. 1997;82:4167–70.
38. Kim HJ, Higashimori T, Park SY et al. Differential effects of
interleukin-6 and -10 on skeletal muscle and liver insulin action in
vivo. Diabetes. 2004;53:1060–7.
39. Kim JH, Kim JE, Liu HY et al. Regulation of interleukin-6-
induced hepatic insulin resistance by mammalian target of
rapamycin through the STAT3-SOCS3 pathway. J Biol Chem.
2008;283:708–15.
40. Mehl KA, Davis JM, Clements JM et al. Decreased intestinal
polyp multiplicity is related to exercise mode and gender in
Apc
Min/+ mice. J Appl Physiol. 2005;98:2219–25.
41. Baltgalvis KA, Berger FG, Peña MM et al. Muscle wasting and
interleukin-6-induced atrogin-I expression in the cachectic Apc
Min/
+ mouse. Pflugers Arch. 2009;457:989–1001.
42. Katsuki A, Sumida Y, Gabazza EC et al. Homeostasis model
assessment is a reliable indicator of insulin resistance during
follow-up of patients with type 2 diabetes. Diabetes Care.
2001;24:362–5.
43. Lieskovska J, Guo D, Derman E. IL-6-overexpression brings about
growthimpairmentpotentiallythroughaGHreceptordefect.Growth
Horm IGF Res. 2002;12:388–98.
44. Zinna EM, Yarasheski KE. Exercise treatment to counteract
protein wasting of chronic diseases. Curr Opin Clin Nutr Metab
Care. 2003;6:87–93.
45. Fouladiun M, Körner U, Gunnebo L et al. Daily physical–rest
activities in relation to nutritional state, metabolism, and quality of
life in cancer patients with progressive cachexia. Clin Cancer Res.
2007;13:6379–85.
46. Holroyde CP, Skutches CL, Boden G et al. Glucose metabolism in
cachectic patients with colorectal cancer. Cancer Res.
1984;44:5910–3.
47. Lelbach A, Muzes G, Feher J. Current perspectives of catabolic
mediators of cancer cachexia. Med Sci Monit. 2007;13:RA168–73.
48. Boudou P, Sobngwi E, Mauvais-Jarvis F et al. Absence of
exercise-induced variations in adiponectin levels despite de-
creased abdominal adiposity and improved insulin sensitivity in
type 2 diabetic men. Eur J Endocrinol. 2003;149:421–4.
49. Mourier A, Gautier JF, De Kerviler E et al. Mobilization of
visceral adipose tissue related to the improvement in insulin
sensitivity in response to physical training in NIDDM. Effects of
branched-chain amino acid supplements. Diabetes Care. 1997;20:
385–91.
50. Tjonna AE, Lee SJ, Rognmo Ø et al. Aerobic interval training
versus continuous moderate exercise as a treatment for the
metabolic syndrome: a pilot study. Circulation. 2008;118:
346–54.
51. Gray SR, Kamolrat T. The effect of exercise induced cytokines on
insulin stimulated glucose transport in C2C12 cells. Cytokine.
2011;55:221–8.
136 J Cachexia Sarcopenia Muscle (2012) 3:117–13752. Makino T, Noguchi Y, Yoshikawa Tet al. Circulating interleukin 6
concentrations and insulin resistance in patients with cancer. Br J
Surg. 1998;85:1658–62.
53. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus
on muscle-derived interleukin-6. Physiol Rev. 2008;88:1379–406.
54. Kim TH, Choi SE, ha ES et al. (2011) IL-6 induction of TLR-4
gene expression via STAT3 has an effect on insulin resistance in
human skeletal muscle. Acta Diabetol [Epub ahead of print]
55. Tisdale MJ. Pathogenesis of cancer cachexia. J Support Oncol.
2003;1:159–68.
56. Silverio R, Laviano A, Fanelli FR et al. (2011) L-Carnitine
induces recovery of liver lipid metabolism in cancer cachexia.
Amino Acids [Epub ahead of print]
57. Lira FS, Tavares FL, Yamashita AS et al. Effect of endurance
training upon lipid metabolism in the liver of cachectic tumour-
bearing rats. Cell Biochem Funct. 2008;26:701–8.
58. Byerley LO, Lee SH, Redmann S, et al. Evidence for a novel
serum factor distinct from zinc alpha-2 glycoprotein that promotes
body fat loss early in the development of cachexia. Nutr Cancer.
2010;62:484–94.
59. Civitarese AE, Ukropcova B, Carling S et al. Role of adiponectin in
human skeletal muscle bioenergetics. Cell Metab. 2006;4:75–87.
60. Morino K, Petersen KF, Shulman GI. Molecular mechanisms of
insulin resistance in humans and their potential links with mitochon-
drial dysfunction. Diabetes. 2006;55:S9–S15.
61. Lanza IR, Nair KS. Muscle mitochondrial changes with aging and
exercise. Am J Clin Nutr. 2009;89:467S–71S.
62. Chomentowski P, Coen P, Radiková Z, et al. Skeletal muscle
mitochondria in insulin resistance: differences in intermyofibrillar
versus subsarcolemmal subpopulations and relationship to metabolic
flexibility. J Clin Endocrinol Metab. 2011;96:494–503.
63. Gosker HR, Hesselink MK, Duimel H et al. Reduced mitochon-
drial density in the vastus lateralis muscle of patients with COPD.
Eur Respir J. 2007;30:73–9.
64. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity
in the quadriceps femoris muscle in patients with severe chronic
obstructive pulmonary disease. Am J Respir Crit Care Med.
1995;151:374–7.
65. Puente-Maestu L, Pérez-Parra J, Godoy R et al. Abnormal
mitochondrial function in locomotor and respiratory muscles of
COPD patients. Eur Respir J. 2009;33:1045–52.
66. De Sousa E, Veksler V, Bigard X et al. Heart failure affects
mitochondrial but not myofibrillar intrinsic properties of skeletal
muscle. Circulation. 2000;102:1847–53.
67. Puppa MJ, White JP, Sato S et al. Gut barrier dysfunction in the
Apc
Min/+ mouse model of colon cancer cachexia. Biochim
Biophys Acta. 2011;1812:1601–6.
68. Kelley DE, He J, Menshikova EV et al. Dysfunction of
mitochondria in human skeletal muscle in type 2 diabetes.
Diabetes. 2002;51:2944–50.
69. Simoneau JA, Kelley DE. Altered glycolytic and oxidative
capacities of skeletal muscle contribute to insulin resistance in
NIDDM. J Appl Physiol. 1997;83:166–71.
70. Sandri M, Sandri C, Gilbert A et al. Foxo transcription factors
induce the atrophy-related ubiquitin ligase atrogin-1 and cause
skeletal muscle atrophy. Cell. 2004;117:399–412.
71. Winder WW. Energy-sensing and signaling by AMP-activated
protein kinase in skeletal muscle. J Appl Physiol. 2001;91:1017–28.
72. Kelly M, Keller C, Avilucea PR et al. AMPK activity is
diminished in tissues of IL-6 knockout mice: the effect of
exercise. Biochem Biophys Res Commun. 2004;320:449–54.
73. Ruderman NB, Keller C, Richard AM et al. Interleukin-6
regulation of AMP-activated protein kinase. Potential role in the
systemic response to exercise and prevention of the metabolic
syndrome. Diabetes. 2006;55 Suppl 2:S48–54.
74. White JP, Baynes JW, Welle SL et al. The regulation of skeletal
muscle protein synthesis during the progression of cancer
cachexia in the Apc
Min/+ mouse. PLoS ONE. 2011;6:e24650.
75. Weidle UH, Klostermann S, Eggle D et al. Interleukin 6/
interleukin 6 receptor interaction and its role as a therapeutic
target for treatment of cachexia and cancer. Cancer Genomics
Proteomics. 2010;7:287–302.
76. Das SK, Eder S, Schauer S, et al. Adipose triglyceride lipase
contributes to cancer-associated cachexia. Science. 2011;333:
233–8.
77. van Hall G, Steensberg A, Sacchetti M et al. Interleukin-6
stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol
Metab. 2003;88:3005–10.
78. Agustsson T, Rydén M, Hoffstedt J et al. Mechanism of increased
lipolysis in cancer cachexia. Cancer Res. 2007;67:5531–7.
79. Guezennec CY, Serrurier B, Aymonod M et al. Metabolic and
hormonal response to short term fasting after endurance training in
the rat. Horm Metab Res. 1984;16:572–5.
80. Shojaee-Moradie F, Baynes KC, Pentecost C et al. Exercise
training reduces fatty acid availability and improves the insulin
sensitivity of glucose metabolism. Diabetologia. 2007;50:404–13.
81. Takahashi M, Terashima M, Takagane A et al. Ghrelin and leptin
levels in cachectic patients with cancer of the digestive organs. Int
J Clin Oncol. 2009;14:315–20.
82. Brichard SM, Delporte ML, Lambert M. Adipocytokines in
anorexia nervosa: a review focusing on leptin and adiponectin.
Horm Metab Res. 2003;35:337–42.
83. Brown DR, Berkowitz DE, Breslow MJ. Weight loss is not
associated with hyperleptinemia in humans with pancreatic cancer.
J Clin Endocrinol Metab. 2001;86:162–6.
84. Smiechowska J, Utech A, Taffet G et al. Adipokines in patients with
cancer anorexia and cachexia. J Investig Med. 2010;58:554–9.
85. vonHaehlingS,MorleyJE,CoatsAJS,AnkerSD.Ethicalguidelines
for authorship and publishing in the Journal of Cachexia, Sarcopenia
and Muscle. J Cachexia Sarcopenia Muscle. 2010;1:7–8.
J Cachexia Sarcopenia Muscle (2012) 3:117–137 137